Annual report pursuant to Section 13 and 15(d)
Cover
Document And Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements of Operations
Consolidated Statements of Operations (Parentheticals)
Consolidated Statements of Comprehensive Income (Loss)
Consolidated Statements of Stockholders??? Equity
Consolidated Statements of Stockholders??? Equity (Parentheticals)
Consolidated Statements of Cash Flows
Notes to Financial Statements
Organization and Business
Discontinued Operations, Sale of Clinical Labs Business
Summary of Significant Accounting Policies
Revenue Recognition
Supplemental Disclosure for Statement of Cash Flows
Inventories
Property, Plant, and Equipment
Income Taxes
Convertible Debentures and Other Current Debt
Long Term Debt
Leases
Accrued Liabilities
Other Current Liabilities
Stockholders??? Equity
Employee Benefit Plans
Commitments
Contingencies
Segment Reporting
Schedule II Valuation and Qualifying Accounts
Accounting Policies
Accounting Policies, by Policy (Policies)
Notes Tables
Discontinued Operations, Sale of Clinical Labs Business (Tables)
Summary of Significant Accounting Policies (Tables)
Revenue Recognition (Tables)
Inventories (Tables)
Property, Plant, and Equipment (Tables)
Income Taxes (Tables)
Convertible Debentures and Other Current Debt (Tables)
Long Term Debt (Tables)
Leases (Tables)
Accrued Liabilities (Tables)
Other Current Liabilities (Tables)
Stockholders??? Equity (Tables)
Employee Benefit Plans (Tables)
Segment Reporting (Tables)
Schedule II Valuation and Qualifying Accounts (Tables)
Notes Details
Discontinued Operations, Sale of Clinical Labs Business (Details)
Discontinued Operations, Sale of Clinical Labs Business (Details) - Schedule of Gain on the Clinical Labs Business and Net Proceeds
Discontinued Operations, Sale of Clinical Labs Business (Details) - Schedule of Condensed Operating Results of the Discontinued Operations
Discontinued Operations, Sale of Clinical Labs Business (Details) - Schedule of Major Classes of Assets and liabilities of the Discontinued Operations
Summary of Significant Accounting Policies (Details)
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share
Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share (Parentheticals)
Summary of Significant Accounting Policies (Details) - Schedule of Expenses Related Share-Based Payment Arrangements
Revenue Recognition (Details) - Schedule of Products Revenue by Geography
Supplemental Disclosure for Statement of Cash Flows (Details)
Inventories (Details) - Schedule of Inventories
Property, Plant, and Equipment (Details)
Property, Plant, and Equipment (Details) - Schedule of Property, Plant, and Equipment
Income Taxes (Details)
Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities
Income Taxes (Details) - Schedule of Income (loss) Before Income Taxes
Income Taxes (Details) - Schedule of Benefit or (provision) for Income Taxes
Convertible Debentures and Other Current Debt (Details)
Convertible Debentures and Other Current Debt (Details) - Schedule of Convertible Debentures Measured at Fair Value
Long Term Debt (Details)
Long Term Debt (Details) - Schedule of Minimum Future Annual Principal Payments
Leases (Details)
Leases (Details) - Schedule of Lease Agreements Include Rental Payments
Leases (Details) - Schedule of Components of Lease Cost
Leases (Details) - Schedule of Lease Liabilities
Leases (Details) - Schedule of Lease Term and Discount Rate
Accrued Liabilities (Details)
Accrued Liabilities (Details) - Schedule of Accrued Liabilities
Other Current Liabilities (Details) - Schedule of Other Current Liabilities
Stockholders??? Equity (Details)
Stockholders??? Equity (Details) - Schedule of Stock Option Activity
Stockholders??? Equity (Details) - Schedule of Assumptions used to Determine the Fair Value of Options Granted
Stockholders??? Equity (Details) - Schedule of Stock Options Outstanding
Stockholders??? Equity (Details) - Schedule of Summarizes Restricted Stock Unit (???RSU???) Activity
Stockholders??? Equity (Details) - Schedule of PSU???s Granted and Outstanding
Employee Benefit Plans (Details)
Employee Benefit Plans (Details) - Schedule of Employee Benefit Plans
Commitments (Details)
Contingencies (Details)
Segment Reporting (Details)
Segment Reporting (Details) - Schedule of Financial Information Represents the Operating Results of the Reportable Segments
Schedule II Valuation and Qualifying Accounts (Details) - Schedule of II Valuation and Qualifying Accounts
Schedule II Valuation and Qualifying Accounts (Tables)
v3.23.3
Schedule II Valuation and Qualifying Accounts (Tables)
12 Months Ended
Jul. 31, 2023
Schedule II Valuation and Qualifying Accounts [Abstract]
Schedule of II Valuation and Qualifying Accounts
Year ended July 31,
Description
Balance at
Beginning
of Year
Charged
(credited)
to costs
and expenses
Charged
to other
accounts
Deductions
Balance at
end of
Year
2023
Allowance for doubtful accounts receivable
$
161
$
9
$
—
$
170
2022
Allowance for doubtful accounts receivable
180
12
31
(1)
161
2023
Deferred tax valuation allowance
34,610
(7,925)
—
26,685
2022
Deferred tax valuation allowance
29,874
4,736
—
34,610
(1)
Write-off of uncollectible accounts receivable.
X
- References
No definition available.
+ Details
Name:
enz_ScheduleIIValuationAndQualifyingAccountsAbstract
Namespace Prefix:
enz_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- References
No definition available.
+ Details
Name:
enz_ScheduleOfIIValuationAndQualifyingAccountsTableTextBlock
Namespace Prefix:
enz_
Data Type:
dtr:textBlockItemType
Balance Type:
na
Period Type:
duration